Teleflex Signs Definitive Agreement to Sell Certain Respiratory Assets and Reaffirms Adjusted EPS Guidance

NEXT STORY
Oxford Biomedica upgrades financial guidance for supply agreement with AstraZeneca for manufacture of COVID-19 Vaccine
PREV STORY
Aprea Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

VBI Vaccines to Present at the H.C. Wainwright 21st Annual Global Investment Conference

author_avatar
NASDAQ Market News

AASM student sleep health resolution introduced in U.S. House of Representatives

author_avatar
NASDAQ Market News

In-Vitro Diagnostics (IVD) Market Worth $118.5 Billion by 2027 – Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®

author_avatar
NASDAQ Market News